Tebeu Pierre-Marie, Ngou-Mve-Ngou Jean Pierre, Zingué Laure Leka, Antaon Jesse Saint Saba, Okobalemba Atenguena Etienne, Dohbit Julius Sama
Department of Obstetrics and Gynaecology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
League of Initiative and Active Research for Women's Health and Education (LIRASEF), Yaoundé, Cameroon.
Obstet Gynecol Int. 2021 Oct 13;2021:1999189. doi: 10.1155/2021/1999189. eCollection 2021.
To analyze the epidemiological aspects of invasive cervical cancer according to HIV status.
This was an historical cohort study from January 2010 to April 2017 in three hospitals at the Yaoundé city Capital, Cameroon, after the National Ethics Committee' approval. We included invasive cervical cancers with documented HIV status. Odds ratios and 95% confidence interval were calculated to assess the association between the different variables and HIV status. Survival was analyzed using the Kaplan-Meier. The level of significance was set up at <5%.
Among the overall 213 cervical cancer patients, 56 were HIV+ (24.67%). Factors associated with positive HIV status were age below 40 (OR: 2.03 (1.38-2.67)), celibacy (OR: 2.88 (1.58-4.17)), nonmenopausal status (OR: 2.56 (1.36-3.75)), low parity, primiparity (OR: 2.59 (1.43-3.74)), and for parity with 2-4 children (OR: 2.24 (1.35-3.12)). Concerning the HIV+ patients, tumor was diagnosed late (stages III-IV) (OR: 2.70 (1.43-5.08)), undifferentiated (grade III) (OR: 7.69 (5.80-9.57)), with low median survival (9.83 months vs. 20.10 months).
HIV is frequent among cervical cancer patients. In the HIV+ patients, the diagnosis was made at the advanced stage, cells were poorly differentiated, and the prognosis was worse.
根据艾滋病毒感染状况分析浸润性宫颈癌的流行病学特征。
这是一项历史性队列研究,于2010年1月至2017年4月在喀麦隆首都雅温得的三家医院进行,经国家伦理委员会批准。我们纳入了有艾滋病毒感染状况记录的浸润性宫颈癌患者。计算优势比和95%置信区间以评估不同变量与艾滋病毒感染状况之间的关联。使用Kaplan-Meier法分析生存率。显著性水平设定为<5%。
在总共213例宫颈癌患者中,56例为艾滋病毒阳性(24.67%)。与艾滋病毒阳性状态相关的因素包括年龄低于40岁(优势比:2.03(1.38 - 2.67))、独身(优势比:2.88(1.58 - 4.17))、未绝经状态(优势比:2.56(1.36 - 3.75))、低生育次数、初产(优势比:2.59(1.43 - 3.74))以及生育2 - 4个孩子(优势比:2.24(1.35 - 3.12))。对于艾滋病毒阳性患者,肿瘤诊断较晚(III - IV期)(优势比:2.70(1.43 - 5.08))、未分化(III级)(优势比:7.69(5.80 - 9.57)),中位生存期较短(9.83个月对20.10个月)。
艾滋病毒在宫颈癌患者中很常见。在艾滋病毒阳性患者中,诊断多在晚期,细胞分化差,预后较差。